Drug Shortage Report for EDARBI

Last updated on 2019-11-19 History
Report ID 93519
Drug Identification Number 02381389
Brand name EDARBI
Common or Proper name EDARBI
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) AZILSARTAN MEDOXOMIL
Strength(s) 40MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28ct
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-08-08
Estimated end date
Actual end date 2019-11-18
Shortage status Resolved
Updated date 2019-11-19
Company comments supplier delay
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2019-11-19 French Compare
v8 2019-11-19 English Compare
v7 2019-10-09 French Compare
v6 2019-10-09 English Compare
v5 2019-09-18 French Compare
v4 2019-09-18 English Compare
v3 2019-09-10 French Compare
v2 2019-09-10 English Compare
v1 2019-09-10 English Compare

Showing 1 to 9 of 9